Indonesia vs Madagascar: Access to anti-retroviral drugs, female
Indonesia
36.0%
in 2024
Madagascar
39.0%
in 2024
Indonesia rank
130th
Madagascar rank
128th
Access to anti-retroviral drugs, female over time
- Indonesia
- Madagascar
How they compare
Madagascar currently reports 39.0% against 36.0% in Indonesia, a difference of 3.0%.
That makes Madagascar's figure about 1.1 times Indonesia's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Madagascar ahead.
Indonesia ranks 130th and Madagascar ranks 128th of 141 countries.
Indonesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.3% | 0.4% | 0.9% | Indonesia |
| 2010s | 12.9% | 4.5% | 8.4% | Indonesia |
| 2020s | 28.8% | 24.6% | 4.2% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Indonesia or Madagascar?
- Madagascar, at 39.0% against 36.0% in Indonesia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Indonesia and Madagascar?
- 3.0%, with Madagascar ahead.
- How many years of comparable data are there for Indonesia and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Indonesia and Madagascar rank globally for access to anti-retroviral drugs, female?
- Indonesia ranks 130th and Madagascar ranks 128th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.